Showing 4871-4880 of 5771 results for "".
- CooperVision Launches First Best Practices Scholarship Programhttps://modernod.com/news/coopervision-launches-first-best-practices-scholarship-program/2477193/To enable future eye care professionals to learn from some of the best in optometry, CooperVision announced the launch of its first “Best Practices Scholarship Program.” The scholarship—offered to third-year optometry students—is an expansion of the company’s annual Best Practices ini
- Lineage Provides Update on Patient Enrollment in Phase 1/2a Clinical Study of OpRegen for the Treatment of Dry AMDhttps://modernod.com/news/lineage-provides-update-on-patient-enrollment-in-phase-1-2a-clinical-study-of-opregen-for-the-treatment-of-dry-amd/2477194/Lineage Cell Therapeutics announced additional patient data from its ongoing phase 1/2a clinical study of OpRegen, the company’s retinal pigment epithelium (RPE) transplant therapy, for the treatment of dry age-related macular degeneration (AMD). The first Cohort 4 patient treated using bo
- Novartis Receives Permanent J-code for Beovuhttps://modernod.com/news/novartis-receives-permanent-j-code-for-beovu/2477192/Novartis announced that it has received a permanent J-code for Beovu (brolucizumab-dbll) injection, effective January 1, 2020. With the permanent J-code, retina specialists may now receive more timely reimbursement for Beovu injections, facilitating access for appropriate patients to this
- 5,736 of the World’s Poorest People Received the Gift of Sight in 2019 at the Tej Kohli Cornea Institutehttps://modernod.com/news/5736-of-the-worlds-poorest-people-received-the-gift-of-sight-in-2019-at-the-tej-kohli-cornea-institute/2477189/On the fourth anniversary of the Tej Kohli Cornea Institute in Hyderabad, the Tej Kohli Foundation has renewed its commitment of $14 million of funding from 2020. During 2019, 5,736 individuals were cured of blindness or severe visual impairment at The Tej Kohli Cornea Institute, according to new
- Allergan Foundation Giving Reaches $95 Million Since Inceptionhttps://modernod.com/news/allergan-foundation-giving-reaches-95-million-since-inception/2477188/Allergan announced that The Allergan Foundation has awarded a total of $10 million in charitable grants in 2019. The grants were donated to more than 400 organizations in 32 states as part of The Allergan Foundation’s commitment to providing a lasting and posit
- Nicox’s NCX 4251 Meets Primary Endpoint in Phase 2 Blepharitis Trial and Shows Promising Efficacy in Dry Eye Diseasehttps://modernod.com/news/nicoxs-ncx-4251-meets-primary-endpoint-in-phase-2-blepharitis-trial-and-shows-promising-efficacy-in-dry-eye-disease/2477187/Nicox SA announced that NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals, has met the primary objective of its U.S. multicenter, dose escalating, first-in-human, phase 2 clinical trial (referred to as ‘Danube’) evaluating the safety and tolerability of NCX 4
- Bausch Health Licenses Novaliq’s NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunctionhttps://modernod.com/news/bausch-health-licenses-novaliqs-nov03-investigational-treatment-for-dry-eye-disease-associated-with-meibomian-gland-dysfunction/2477185/Bausch Health Companies and Novaliq have announced that Bausch Health has acquired an exclusive license for the commercialization and development in the United States and Canada of the investigational treatment NOV03 (perfluorohexy
- ProtoKinetix AAGP Retinal Cell Replacement Therapy Testing at UBC Completedhttps://modernod.com/news/protokinetix-aagp-retinal-cell-replacement-therapy-testing-at-ubc-completed/2477184/ProtoKinetix announced the completion of an in vivo study to assess the effect of AAGP on the long term survival and functional activity of photoreceptor precursor cells (PPCs) in the animal ocular model of genetic retinal degeneration. The objective of this study was to determine t
- With EyeCare Partners Deal, Swiss Firm Sees a Base for ‘Organic Growth, Expansion and Consolidation’ of U.S. Vision Markethttps://modernod.com/news/with-eyecare-partners-deal-swiss-firm-sees-a-base-for-organic-growth-expansion-and-consolidation-of-u-s-vision-market/2477176/In the second major acquisition of an eyecare practice management group this year, the Switzerland-based Partners Group announced Monday morning that it has agreed to make a significant investment in EyeCare Partners LLC (ECP). FFL Partners announced separately that it was selling the stake it ha
- 1-800 Contacts Enters Agreement to Acquire Vision Start-Up 6over6 Visionhttps://modernod.com/news/1-800-contacts-enters-agreement-to-acquire-vision-start-up-6over6-vision/2477177/1-800 Contacts announced that it entered into a definitive agreement to acquire 6over6 Vision (6over6), a provider of at-home vision tests using a mobile app or computer. Terms of the deal were not disclosed. 6over6 currently offers a vari